Table 4

Factors associated with ART adherence among adult patients on ART in public health institutions in South Gondar zone, 1 August 2020–31 January 2021

Adherence to ARVCOR (95% CI)AOR (95% CI)P value
AdherentNon-adherent
Drug other than ARV
 No2755311
 Yes77270.55 (0.3 to 0.9)1.14 (0.53 to 2.45)
Stigmatised and discriminated patients on ART
 No3266111
 Yes26160.26 (0.13 to 0.5)0.4 (0.2 to 0.84)0.016
Missed scheduled clinical visit
 No3256111
 Yes27190.27 (0.14 to 0.51)0.45 (0.21 to 0.94)0.034
Patients on TB treatment
 No2975011
 Yes55300.41 (0.18 to 0.53)0.45 (0.24 to 0.83)0.01
Recent CD4 count
 ≥500 cells/mm332865110.023
 <500 cells/mm327170.23 (0.12 to 0.56)0.3 (0.14 to 0.73)0.007
WHO clinical stage at the time of ART initiation
 Stage I4281
 Stage II291610.208 (0.68 to 0.633)
 Stage III12110.23 (0.1 to 0.55)0.24 (0.098 to 0.57)0.027
  • AOR, adjusted OR; ART, antiretroviral therapy; ARV, antiretroviral; TB, tuberculosis.